Existing investors KKR & Co LP and Warburg Pincus LLC are also participating in the funding round.
Sequoia Capital China, China Renaissance Principal Investment, Sunac Capital, GA Capital, H Capital, Source Code Capital, Haixia Asset, and New Hope also joined the round
Space Cycle, which operates six boutique fitness studios in Beijing, Shanghai and Taipei, plans to use the funding to expand in China.
Existing investor, GGV invested RMB100 million ($15 million) in July 2017 prior to this latest investment round.
The two-year-old Huangzhou-based firm’s Series A round was participated by various unnamed domestic and overseas investors.
Other investors in the round include Canadian venture capital BDC, Kickstart Ventures, Peterson Group and existing investor Raine.
The firm has also launched an ICO with a target fundraise of $25 million through the sale of 125 million Morpheus Infrastructure Tokens
The company is targeting around $1 billion of financing. Its targeted valuation would be almost six times the $3 billion it managed when it last raised funds in March.
Aprinoia Therapeutics said it will use the proceeds of the funding to finance preclinical and clinical development.
About 1,800 startups have raised over $700 million through Syndicates on the AngelList platform.